Bone loss in perimenopausal women: a longitudinal study

Area of Science:

• Endocrinology
• Bone Metabolism
• Reproductive Health

Background:

• Menstrual irregularities in premenopausal women can indicate underlying hormonal imbalances.
• Ovarian function plays a crucial role in maintaining bone mineral density (BMD).
• Understanding the link between menstrual patterns and bone health is vital for early intervention.

Purpose of the Study:

• To longitudinally evaluate bone mineral density (BMD) and metabolic markers in premenopausal women with regular (eumenorrheic) versus irregular (oligomenorrheic) menstrual cycles.
• To investigate the relationship between hormonal profiles (estradiol, FSH) and bone metabolism in these groups.

Main Methods:

• Longitudinal study over 2 years.
• Recruited premenopausal women divided into eumenorrheic and oligomenorrheic groups (n=37 each).
• Monitored menstrual patterns, plasma estradiol and FSH levels, urinary hydroxyproline to creatinine ratio (OH-P/Cr), plasma bone Gla protein (BGP), and radial BMD.

Main Results:

• Eumenorrheic women showed no significant changes in menstrual patterns, hormones, bone markers, or BMD.
• Oligomenorrheic women exhibited longer cycles, increased FSH, decreased estradiol, elevated OH-P/Cr and BGP, and a significant decrease in radial BMD.
• These changes were statistically significant (P < 0.05).

Conclusions:

• Premenopausal impairment of ovarian function, as seen in oligomenorrhea, is associated with significant bone loss.
• Bone loss occurs alongside hormonal changes and altered bone turnover markers.
• Preventive strategies should be considered for women experiencing premenopausal ovarian dysfunction to mitigate future osteoporosis risk.